| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 30 | 2025 | 208 | 12.590 |
Why?
|
| Coronary Artery Disease | 18 | 2025 | 310 | 9.330 |
Why?
|
| Shock, Cardiogenic | 6 | 2025 | 102 | 4.830 |
Why?
|
| Drug-Eluting Stents | 7 | 2023 | 62 | 4.490 |
Why?
|
| ST Elevation Myocardial Infarction | 10 | 2025 | 90 | 4.340 |
Why?
|
| Myocardial Infarction | 10 | 2025 | 913 | 3.560 |
Why?
|
| Cardiac Catheterization | 10 | 2020 | 281 | 3.470 |
Why?
|
| Coronary Angiography | 14 | 2025 | 201 | 2.930 |
Why?
|
| Coronary Artery Bypass | 11 | 2023 | 297 | 2.140 |
Why?
|
| Registries | 11 | 2025 | 887 | 2.090 |
Why?
|
| Coronary Stenosis | 4 | 2025 | 39 | 1.990 |
Why?
|
| Fractional Flow Reserve, Myocardial | 4 | 2018 | 19 | 1.900 |
Why?
|
| Treatment Outcome | 28 | 2025 | 5654 | 1.860 |
Why?
|
| Hospital Mortality | 5 | 2025 | 874 | 1.800 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2021 | 22 | 1.690 |
Why?
|
| Coronary Vessels | 4 | 2019 | 118 | 1.560 |
Why?
|
| Stents | 7 | 2025 | 491 | 1.540 |
Why?
|
| Aortic Valve Stenosis | 3 | 2022 | 188 | 1.510 |
Why?
|
| Retrospective Studies | 22 | 2025 | 6631 | 1.420 |
Why?
|
| Time-to-Treatment | 3 | 2025 | 111 | 1.420 |
Why?
|
| Heart Failure | 4 | 2022 | 915 | 1.190 |
Why?
|
| Catheterization, Peripheral | 2 | 2019 | 53 | 1.190 |
Why?
|
| Humans | 56 | 2025 | 63292 | 1.140 |
Why?
|
| Hemodynamics | 3 | 2025 | 248 | 1.090 |
Why?
|
| Mortality | 2 | 2019 | 160 | 1.020 |
Why?
|
| Male | 33 | 2025 | 29820 | 0.980 |
Why?
|
| Vascular Diseases | 3 | 2021 | 81 | 0.940 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2021 | 172 | 0.920 |
Why?
|
| Coronary Circulation | 1 | 2025 | 52 | 0.910 |
Why?
|
| Acute Coronary Syndrome | 2 | 2023 | 253 | 0.900 |
Why?
|
| Radial Artery | 4 | 2020 | 53 | 0.890 |
Why?
|
| Heart-Assist Devices | 2 | 2024 | 144 | 0.890 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2025 | 49 | 0.890 |
Why?
|
| Models, Cardiovascular | 1 | 2025 | 79 | 0.880 |
Why?
|
| Coronary Thrombosis | 3 | 2018 | 21 | 0.860 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 107 | 0.820 |
Why?
|
| Risk Factors | 14 | 2023 | 5343 | 0.820 |
Why?
|
| Radiologists | 3 | 2019 | 89 | 0.790 |
Why?
|
| Middle Aged | 22 | 2025 | 17550 | 0.780 |
Why?
|
| Respiration, Artificial | 1 | 2025 | 297 | 0.760 |
Why?
|
| Female | 27 | 2025 | 32790 | 0.750 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2023 | 226 | 0.740 |
Why?
|
| Anemia | 1 | 2023 | 127 | 0.730 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 146 | 0.730 |
Why?
|
| Cardiology | 2 | 2020 | 167 | 0.710 |
Why?
|
| Cardiologists | 2 | 2019 | 28 | 0.710 |
Why?
|
| Atherosclerosis | 1 | 2022 | 153 | 0.700 |
Why?
|
| Aged | 16 | 2025 | 14392 | 0.700 |
Why?
|
| Hirudins | 2 | 2019 | 12 | 0.670 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 165 | 0.670 |
Why?
|
| Middle East | 3 | 2025 | 10 | 0.650 |
Why?
|
| Ankle Brachial Index | 1 | 2019 | 13 | 0.650 |
Why?
|
| Myocardial Revascularization | 2 | 2022 | 76 | 0.640 |
Why?
|
| Saphenous Vein | 1 | 2020 | 52 | 0.640 |
Why?
|
| Ticlopidine | 2 | 2011 | 49 | 0.630 |
Why?
|
| Aneurysm | 1 | 2020 | 60 | 0.620 |
Why?
|
| Heparin | 2 | 2019 | 116 | 0.620 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 56 | 0.620 |
Why?
|
| Chest Pain | 1 | 2019 | 84 | 0.610 |
Why?
|
| Exercise Test | 2 | 2019 | 252 | 0.600 |
Why?
|
| Angina, Stable | 2 | 2016 | 11 | 0.590 |
Why?
|
| Peptide Fragments | 2 | 2019 | 410 | 0.570 |
Why?
|
| Betacoronavirus | 1 | 2020 | 183 | 0.570 |
Why?
|
| Cardiology Service, Hospital | 1 | 2017 | 17 | 0.560 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 538 | 0.550 |
Why?
|
| Patient Care Team | 2 | 2017 | 337 | 0.550 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 210 | 0.530 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 224 | 0.530 |
Why?
|
| Blood Pressure | 2 | 2018 | 509 | 0.500 |
Why?
|
| Tomography, Optical Coherence | 2 | 2020 | 223 | 0.490 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 16 | 0.470 |
Why?
|
| Thrombosis | 1 | 2017 | 199 | 0.460 |
Why?
|
| Bradycardia | 1 | 2015 | 33 | 0.460 |
Why?
|
| Cicatrix | 1 | 2015 | 61 | 0.460 |
Why?
|
| Hemorrhage | 3 | 2023 | 267 | 0.460 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 28 | 0.450 |
Why?
|
| Incidence | 5 | 2020 | 1376 | 0.440 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 108 | 0.440 |
Why?
|
| After-Hours Care | 1 | 2014 | 7 | 0.440 |
Why?
|
| Candidiasis | 1 | 2014 | 51 | 0.430 |
Why?
|
| Endocarditis | 1 | 2014 | 29 | 0.430 |
Why?
|
| Embolism | 1 | 2014 | 41 | 0.430 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 1542 | 0.430 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 216 | 0.390 |
Why?
|
| Residence Characteristics | 1 | 2014 | 220 | 0.390 |
Why?
|
| Renal Circulation | 1 | 2012 | 14 | 0.380 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 8 | 0.380 |
Why?
|
| Thrombectomy | 1 | 2014 | 234 | 0.380 |
Why?
|
| Consensus | 3 | 2020 | 232 | 0.380 |
Why?
|
| Ischemic Preconditioning | 1 | 2012 | 8 | 0.380 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2012 | 28 | 0.370 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 53 | 0.360 |
Why?
|
| Coronary Restenosis | 1 | 2011 | 20 | 0.360 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1082 | 0.360 |
Why?
|
| Endpoint Determination | 1 | 2011 | 25 | 0.360 |
Why?
|
| Stroke Volume | 2 | 2022 | 330 | 0.330 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 269 | 0.330 |
Why?
|
| Aspirin | 1 | 2011 | 171 | 0.330 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 112 | 0.320 |
Why?
|
| Massachusetts | 5 | 2019 | 2076 | 0.320 |
Why?
|
| Physicians | 1 | 2014 | 470 | 0.290 |
Why?
|
| Heptanoic Acids | 1 | 2008 | 22 | 0.280 |
Why?
|
| Pyrroles | 1 | 2008 | 51 | 0.280 |
Why?
|
| Physician's Role | 2 | 2019 | 124 | 0.270 |
Why?
|
| Electrocardiography | 3 | 2020 | 555 | 0.240 |
Why?
|
| Ultrasonography, Doppler | 1 | 2025 | 27 | 0.230 |
Why?
|
| Hydrodynamics | 1 | 2025 | 37 | 0.230 |
Why?
|
| Prospective Studies | 5 | 2020 | 3283 | 0.230 |
Why?
|
| Time Factors | 3 | 2025 | 3761 | 0.220 |
Why?
|
| Prevalence | 2 | 2020 | 1377 | 0.210 |
Why?
|
| Prognosis | 3 | 2018 | 1747 | 0.210 |
Why?
|
| Dissection | 2 | 2021 | 48 | 0.210 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 834 | 0.200 |
Why?
|
| Computational Biology | 1 | 2025 | 356 | 0.200 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2457 | 0.200 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 936 | 0.200 |
Why?
|
| Stroke | 1 | 2011 | 1192 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 148 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 1650 | 0.190 |
Why?
|
| Dobutamine | 1 | 2021 | 10 | 0.190 |
Why?
|
| Echocardiography | 1 | 2025 | 500 | 0.180 |
Why?
|
| Job Description | 2 | 2019 | 24 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 455 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 1615 | 0.180 |
Why?
|
| Unemployment | 1 | 2021 | 18 | 0.170 |
Why?
|
| Kidney | 1 | 2023 | 447 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 768 | 0.170 |
Why?
|
| Oxygen | 2 | 2020 | 315 | 0.170 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 32 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 36 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 701 | 0.160 |
Why?
|
| Aortic Valve | 1 | 2021 | 190 | 0.160 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2020 | 74 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2018 | 568 | 0.160 |
Why?
|
| Antithrombins | 1 | 2019 | 15 | 0.160 |
Why?
|
| Global Health | 1 | 2020 | 183 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 165 | 0.150 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 32 | 0.150 |
Why?
|
| Hemostatic Techniques | 1 | 2018 | 11 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 96 | 0.150 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2018 | 7 | 0.150 |
Why?
|
| Hyperoxia | 1 | 2018 | 17 | 0.150 |
Why?
|
| Punctures | 1 | 2018 | 64 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2019 | 110 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2017 | 2076 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 169 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 196 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 193 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2017 | 1302 | 0.140 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2017 | 24 | 0.130 |
Why?
|
| Widowhood | 1 | 2017 | 5 | 0.130 |
Why?
|
| Logistic Models | 3 | 2017 | 1274 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 105 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 417 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 261 | 0.130 |
Why?
|
| Referral and Consultation | 2 | 2017 | 422 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 129 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2019 | 217 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2019 | 725 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 222 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 190 | 0.120 |
Why?
|
| Theophylline | 1 | 2015 | 10 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 672 | 0.120 |
Why?
|
| Treatment Refusal | 1 | 2015 | 56 | 0.120 |
Why?
|
| Adult | 5 | 2021 | 16785 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1000 | 0.110 |
Why?
|
| Polysomnography | 1 | 2015 | 57 | 0.110 |
Why?
|
| Inpatients | 1 | 2017 | 303 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 104 | 0.110 |
Why?
|
| Suction | 1 | 2014 | 36 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 463 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 124 | 0.110 |
Why?
|
| Prosthesis Design | 1 | 2015 | 227 | 0.110 |
Why?
|
| Antifungal Agents | 1 | 2014 | 127 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2014 | 66 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 372 | 0.100 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 168 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2019 | 2569 | 0.100 |
Why?
|
| Pregnancy | 1 | 2020 | 2333 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2017 | 495 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1146 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 712 | 0.090 |
Why?
|
| Troponin | 1 | 2012 | 38 | 0.090 |
Why?
|
| Creatinine | 1 | 2012 | 136 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 2569 | 0.090 |
Why?
|
| Sirolimus | 1 | 2011 | 92 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2011 | 99 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2011 | 147 | 0.090 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 21 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2010 | 32 | 0.080 |
Why?
|
| Patients | 1 | 2011 | 113 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 377 | 0.080 |
Why?
|
| United States | 2 | 2018 | 7825 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2010 | 151 | 0.070 |
Why?
|
| Myocardium | 1 | 2010 | 274 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 29 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 469 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1232 | 0.070 |
Why?
|
| Health Promotion | 1 | 2011 | 497 | 0.060 |
Why?
|
| Liver | 1 | 2010 | 851 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 762 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 768 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 834 | 0.050 |
Why?
|
| Wrist | 1 | 2020 | 39 | 0.040 |
Why?
|
| Arabs | 1 | 2019 | 8 | 0.040 |
Why?
|
| Hematoma | 1 | 2020 | 80 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2018 | 13 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 69 | 0.040 |
Why?
|
| Specialization | 1 | 2019 | 81 | 0.040 |
Why?
|
| Workload | 1 | 2019 | 126 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 198 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 209 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2017 | 7 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2017 | 4 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 108 | 0.030 |
Why?
|
| Leadership | 1 | 2019 | 206 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 20622 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 350 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 849 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 777 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2016 | 177 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 979 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 317 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 488 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1558 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2011 | 246 | 0.020 |
Why?
|
| Cholesterol | 1 | 2011 | 259 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2167 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 444 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 281 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 864 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 865 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 5449 | 0.020 |
Why?
|
| Hypertension | 1 | 2011 | 585 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 940 | 0.010 |
Why?
|